TCR2 Therapeutics (TCRR) PT Lowered to $4 at Wedbush
Tweet
Share
E-mailGet Alerts TCRR Hot Sheet
Price: $2.89 -0.34%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Wedbush analyst David Nierengarten lowered the price target on TCR2 Therapeutics (NASDAQ: TCRR) to $4.00 (from $8.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Anglo American Plc. (AAL:LN) (NGLOY) PT Raised to GBP38 at JPMorgan
- Mindtree Ltd (MTCL:IN) PT Lowered to INR2,700 at UBS
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR3,570 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
